TG Therapeutics PE Ratio 2010-2023 | TGTX
Current and historical p/e ratio for TG Therapeutics (TGTX) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. TG Therapeutics PE ratio as of April 22, 2024 is 689.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
TG Therapeutics PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-22 | 14.10 | 705.00 | |
2023-12-31 | 17.08 | $0.02 | 854.00 |
2023-09-30 | 8.36 | $-0.28 | 0.00 |
2023-06-30 | 24.84 | $-1.27 | 0.00 |
2023-03-31 | 15.04 | $-1.23 | 0.00 |
2022-12-31 | 11.83 | $-1.46 | 0.00 |
2022-09-30 | 5.92 | $-1.77 | 0.00 |
2022-06-30 | 4.25 | $-2.16 | 0.00 |
2022-03-31 | 9.51 | $-2.45 | 0.00 |
2021-12-31 | 19.00 | $-2.63 | 0.00 |
2021-09-30 | 33.28 | $-2.64 | 0.00 |
2021-06-30 | 38.79 | $-2.72 | 0.00 |
2021-03-31 | 48.20 | $-2.60 | 0.00 |
2020-12-31 | 52.02 | $-2.39 | 0.00 |
2020-09-30 | 26.76 | $-2.12 | 0.00 |
2020-06-30 | 19.48 | $-2.08 | 0.00 |
2020-03-31 | 9.84 | $-2.03 | 0.00 |
2019-12-31 | 11.10 | $-1.98 | 0.00 |
2019-09-30 | 5.62 | $-1.54 | 0.00 |
2019-06-30 | 8.65 | $-1.28 | 0.00 |
2019-03-31 | 8.04 | $-1.45 | 0.00 |
2018-12-31 | 4.10 | $-1.61 | 0.00 |
2018-09-30 | 5.60 | $-2.07 | 0.00 |
2018-06-30 | 13.15 | $-2.12 | 0.00 |
2018-03-31 | 14.20 | $-1.98 | 0.00 |
2017-12-31 | 8.20 | $-1.91 | 0.00 |
2017-09-30 | 11.85 | $-1.93 | 0.00 |
2017-06-30 | 10.05 | $-1.95 | 0.00 |
2017-03-31 | 11.65 | $-1.83 | 0.00 |
2016-12-31 | 4.65 | $-1.59 | 0.00 |
2016-09-30 | 7.74 | $-1.48 | 0.00 |
2016-06-30 | 6.06 | $-1.26 | 0.00 |
2016-03-31 | 8.52 | $-1.31 | 0.00 |
2015-12-31 | 11.93 | $-1.42 | 0.00 |
2015-09-30 | 10.08 | $-1.53 | 0.00 |
2015-06-30 | 16.59 | $-1.76 | 0.00 |
2015-03-31 | 15.48 | $-1.74 | 0.00 |
2014-12-31 | 15.84 | $-1.60 | 0.00 |
2014-09-30 | 10.67 | $-1.31 | 0.00 |
2014-06-30 | 9.39 | $-0.96 | 0.00 |
2014-03-31 | 6.90 | $-0.89 | 0.00 |
2013-12-31 | 3.90 | $-0.81 | 0.00 |
2013-09-30 | 5.04 | $-0.66 | 0.00 |
2013-06-30 | 6.39 | $-0.66 | 0.00 |
2013-03-31 | 5.40 | $-0.37 | 0.00 |
2012-12-31 | 3.64 | $-0.20 | 0.00 |
2012-09-30 | 2.25 | $-0.16 | 0.00 |
2012-06-30 | 6.25 | $1.69 | 3.71 |
2012-03-31 | 6.75 | $1.69 | 4.00 |
2011-12-31 | 1.13 | $1.69 | 0.67 |
2011-03-31 | 28.13 | $57.87 | 0.49 |
2010-12-31 | 56.25 | $47.19 | 1.19 |
2010-09-30 | 84.38 | $-17.42 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $2.130B | $0.234B |
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
Stryker (SYK) | United States | $123.816B | 30.70 |
Medtronic (MDT) | Ireland | $105.535B | 14.94 |
Boston Scientific (BSX) | United States | $98.780B | 32.84 |
EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
ResMed (RMD) | United States | $26.307B | 26.30 |
Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
Terumo (TRUMY) | Japan | $24.492B | 34.59 |
Baxter (BAX) | United States | $20.044B | 14.62 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.641B | 61.12 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
Demant (WILYY) | Denmark | $9.965B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
Haemonetics (HAE) | United States | $4.126B | 21.10 |
GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
Envista Holdings (NVST) | United States | $3.430B | 13.05 |
QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
Neogen (NEOG) | United States | $2.515B | 24.19 |
ICU Medical (ICUI) | United States | $2.333B | 17.41 |
Owens & Minor (OMI) | United States | $1.899B | 18.23 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
InMode (INMD) | Israel | $1.462B | 7.57 |
LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
Warby Parker (WRBY) | United States | $1.185B | 0.00 |
AtriCure (ATRC) | United States | $1.122B | 0.00 |
MacroGenics (MGNX) | United States | $0.977B | 0.00 |
Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
Evolus (EOLS) | United States | $0.668B | 0.00 |
Quanterix (QTRX) | United States | $0.605B | 0.00 |
Jin Medical (ZJYL) | China | $0.600B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
Valneva SE (VALN) | France | $0.528B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
PetIQ (PETQ) | United States | $0.479B | 17.89 |
ZimVie (ZIMV) | United States | $0.420B | 25.72 |
Biote (BTMD) | United States | $0.413B | 3.93 |
OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
Surmodics (SRDX) | United States | $0.377B | 40.75 |
Zynex (ZYXI) | United States | $0.366B | 42.15 |
Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Veru (VERU) | United States | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
High Tide (HITI) | Canada | $0.179B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.101B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.091B | 0.00 |
Brainsway (BWAY) | Israel | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
United Health Products (UEEC) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.30 |
Modular Medical (MODD) | United States | $0.036B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |